These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 37546079)
1. Demographics and Clinical Characteristics of Patients With Opioid Use Disorder and Offered Medication-Assisted Treatment in the Emergency Department. Fu W; Adzhiashvili V; Majlesi N Cureus; 2023 Jul; 15(7):e41464. PubMed ID: 37546079 [TBL] [Abstract][Full Text] [Related]
2. Development of an Emergency Department-Based Intervention to Expand Access to Medications for Opioid Use Disorder in a Medicaid Nonexpansion Setting: Protocol for Engagement and Community Collaboration. Walter LA; Li L; Rodgers JB; Hess JJ; Skains RM; Delaney MC; Booth J; Hess EP JMIR Res Protoc; 2021 Apr; 10(4):e18734. PubMed ID: 33913818 [TBL] [Abstract][Full Text] [Related]
3. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting. Cisewski DH; Santos C; Koyfman A; Long B Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476 [TBL] [Abstract][Full Text] [Related]
4. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study. Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697 [TBL] [Abstract][Full Text] [Related]
5. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder. Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535 [TBL] [Abstract][Full Text] [Related]
6. Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population. Ferries E; Racsa P; Bizzell B; Rhodes C; Suehs B J Manag Care Spec Pharm; 2021 May; 27(5):596-606. PubMed ID: 33908274 [No Abstract] [Full Text] [Related]
7. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results. Klein AA; Seppala MD J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985 [TBL] [Abstract][Full Text] [Related]
8. Nudging Emergency Department-Initiated Addiction Treatment. Butler K; Chavez T; Wakeman S; Robertson T; Leifer J; Barofsky J; Kao LS; Lefkowitz J; Dutta S; Hayes B; White B; Raja A; Martin A J Addict Med; 2022 Jul-Aug 01; 16(4):e234-e239. PubMed ID: 34775439 [TBL] [Abstract][Full Text] [Related]
9. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440 [TBL] [Abstract][Full Text] [Related]
10. Healthcare Use After Buprenorphine Prescription in a Community Emergency Department: A Cohort Study. Le T; Cordial P; Sankoe M; Purnode C; Parekh A; Baker T; Hiestand B; Peacock WF; Neuenschwander J West J Emerg Med; 2021 Sep; 22(6):1270-1275. PubMed ID: 34787550 [TBL] [Abstract][Full Text] [Related]
11. Review of medication-assisted treatment for opioid use disorder. Ghanem N; Dromgoole D; Hussein A; Jermyn RT J Osteopath Med; 2022 Mar; 122(7):367-374. PubMed ID: 35285220 [TBL] [Abstract][Full Text] [Related]
12. Retrospective Review of a Novel Approach to Buprenorphine Induction in the Emergency Department. Dunkley CA; Carpenter JE; Murray BP; Sizemore E; Wheatley M; Morgan BW; Moran TP; Steck A J Emerg Med; 2019 Aug; 57(2):181-186. PubMed ID: 31060846 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. Kaucher KA; Caruso EH; Sungar G; Gawenus L; Hurlbut K; Sanchez DC; Broderick K Am J Emerg Med; 2020 Feb; 38(2):300-304. PubMed ID: 31387811 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of Treatments for Opioid Use Disorder. Fairley M; Humphreys K; Joyce VR; Bounthavong M; Trafton J; Combs A; Oliva EM; Goldhaber-Fiebert JD; Asch SM; Brandeau ML; Owens DK JAMA Psychiatry; 2021 Jul; 78(7):767-777. PubMed ID: 33787832 [TBL] [Abstract][Full Text] [Related]
15. Opioid Treatment Deserts: Concept development and application in a US Midwestern urban county. Hyder A; Lee J; Dundon A; Southerland LT; All D; Hammond G; Miller HJ PLoS One; 2021; 16(5):e0250324. PubMed ID: 33979342 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans. Kirby T; Connell R; Linneman T Am J Health Syst Pharm; 2021 Feb; 78(4):301-309. PubMed ID: 33289022 [TBL] [Abstract][Full Text] [Related]
17. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers. Hu T; Snider-Adler M; Nijmeh L; Pyle A CJEM; 2019 Jul; 21(4):492-498. PubMed ID: 31006398 [TBL] [Abstract][Full Text] [Related]
18. Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department. Martin A; Butler K; Chavez T; Herring A; Wakeman S; Hayes BD; Raja A West J Emerg Med; 2020 Nov; 21(6):257-263. PubMed ID: 33207174 [TBL] [Abstract][Full Text] [Related]
19. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge. Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457 [TBL] [Abstract][Full Text] [Related]
20. A National Survey of Pediatric Emergency Medicine Clinicians' Comfort Level, Beliefs, and Experiences With Initiating Buprenorphine in the Emergency Department. Rittenhouse D; Sandelich S Cureus; 2024 Sep; 16(9):e69331. PubMed ID: 39398852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]